Literature DB >> 30542716

SMAD specific E3 ubiquitin protein ligase 1 promotes ovarian cancer cell migration and invasion via the activation of the RhoA/ROCK signaling pathway.

Wei Wang1, Han Du1, Huiping Liu1, Fangfang Hu1, Guangzhi Liu1.   

Abstract

SMAD specific E3 ubiquitin protein ligase 1 (SMURF1) serves a pivotal role in a variety of pathological processes and in tumor cell migration and invasion; however, its functional mechanism in ovarian cancer (OC) remains unknown. Previously, we observed overexpression of SMURF1 in OC tissues. In the present study, the role of SMURF1 in OC metastasis was investigated. The results revealed that SMURF1 was upregulated in OC cell lines of greater aggression than less aggressive cells. Downregulation of SMURF1 significantly inhibited OC cell invasion and migration, whereas upregulation of SMURF1 promoted OC cell invasion and migration. Investigation of the mechanism underlying the effects of SMURF1 in OC revealed that SMURF1 induced OC cell migration and invasion via activation of the Ras homolog family member A/Rho‑associated protein kinase signaling pathway. Further analysis demonstrated that higher levels of SMURF1 expression were associated with shorter overall survival in patients with OC. The findings of the present study indicated that overexpression of SMURF1 may contribute to the malignancy and metastasis of OC. The inhibition of SMURF1 expression may be a promising strategy for the treatment of patients with OC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30542716     DOI: 10.3892/or.2018.6836

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  Diosgenin and GSK126 Produce Synergistic Effects on Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway.

Authors:  Shanshan Liu; Guihong Rong; Xia Li; Lijun Geng; Zhineng Zeng; Dongxiang Jiang; Jun Yang; Yesheng Wei
Journal:  Onco Targets Ther       Date:  2020-06-08       Impact factor: 4.147

2.  Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer.

Authors:  Wei Wang; Jinshu Wang; Xinzhong Zhang; Gang Liu
Journal:  Onco Targets Ther       Date:  2019-09-11       Impact factor: 4.147

3.  Effects of Laparoscopic Hyperthermic Perfusion Therapy Combined with Adjuvant Treatment of Compound Yew Capsule on Ovarian Blood Flow Parameters and Immune Function in Patients with Ovarian Cancer.

Authors:  Mengya Su; Donghui Wang; Ping Huang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-13       Impact factor: 2.650

Review 4.  SMURF1, a promoter of tumor cell progression?

Authors:  Qin Xia; Yang Li; Da Han; Lei Dong
Journal:  Cancer Gene Ther       Date:  2020-11-17       Impact factor: 5.987

Review 5.  Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer.

Authors:  Jerry Vriend; Mark W Nachtigal
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.